- Home
- IMNM vs IGIC Comparison
IMNM vs IGIC Comparison
Compare IMNM & IGIC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- IMNM
- IGIC
- Stock Information
- Founded
- IMNM 2006
- IGIC 2001
- Country
- IMNM United States
- IGIC Jordan
- Employees
- IMNM N/A
- IGIC N/A
- Industry
- IMNM Medicinal Chemicals and Botanical Products
- IGIC Property-Casualty Insurers
- Sector
- IMNM Health Care
- IGIC Finance
- Exchange
- IMNM Nasdaq
- IGIC Nasdaq
- Market Cap
- IMNM 945.8M
- IGIC 1.0B
- IPO Year
- IMNM 2020
- IGIC N/A
- Fundamental
- Price
- IMNM $9.69
- IGIC $24.36
- Analyst Decision
- IMNM Strong Buy
- IGIC Buy
- Analyst Count
- IMNM 8
- IGIC 2
- Target Price
- IMNM $24.75
- IGIC $31.50
- AVG Volume (30 Days)
- IMNM 756.6K
- IGIC 64.9K
- Earning Date
- IMNM 08-06-2025
- IGIC 11-04-2025
- Dividend Yield
- IMNM N/A
- IGIC 0.41%
- EPS Growth
- IMNM N/A
- IGIC 11.00
- EPS
- IMNM N/A
- IGIC 2.79
- Revenue
- IMNM $12,589,000.00
- IGIC $535,109,000.00
- Revenue This Year
- IMNM N/A
- IGIC $6.05
- Revenue Next Year
- IMNM $154.73
- IGIC $7.01
- P/E Ratio
- IMNM N/A
- IGIC $8.65
- Revenue Growth
- IMNM 16.74
- IGIC 9.99
- 52 Week Low
- IMNM $5.15
- IGIC $17.06
- 52 Week High
- IMNM $16.73
- IGIC $27.76
- Technical
- Relative Strength Index (RSI)
- IMNM 48.73
- IGIC 53.53
- Support Level
- IMNM $8.67
- IGIC $23.81
- Resistance Level
- IMNM $9.71
- IGIC $24.30
- Average True Range (ATR)
- IMNM 0.63
- IGIC 0.46
- MACD
- IMNM -0.04
- IGIC -0.02
- Stochastic Oscillator
- IMNM 51.64
- IGIC 42.18
About IMNM Immunome Inc.
Immunome Inc is a biopharmaceutical company. It is engaged in utilizing a proprietary human memory B cell platform to discover and develop first-in-class antibody therapeutics designed to change the way diseases are currently being treated. The objective of the company is to establish a broad pipeline of preclinical and clinical assets which it can efficiently develop through successive value inflection points. The company's primary focus areas are oncology and infectious diseases, including COVID-19. It operates in the U.S. Its current pipelines comprise IM-1021, a fibroblast activation protein (FAP), and others.
About IGIC International General Insurance Holdings Ltd.
International General Insurance Holdings Ltd is an international specialist commercial insurer and a reinsurer, underwriting a diverse portfolio of specialty lines. The company operates in a portfolio of Energy, Property, Construction, Engineering, Ports and terminals, Financial Institutions, General Aviation, Professional Indemnity, Casualty, Directors and Officers, Political Violence, Forestry, and Treaty Reinsurance. Its operating segment includes Specialty Longtail; Specialty Short tail and Reinsurance.